Rare Ebola Strain Spreads Rapidly in Congo as Global Alarm Grows

The first confirmed recoveries from a rare and little-understood strain of Ebola offer a glimmer of hope in an outbreak that is otherwise accelerating at an alarming pace. Five patients infected with the Bundibugyo virus were discharged from a treatment centre in Bunia, eastern Democratic Republic of Congo, the World Health Organization’s director-general Tedros Adhanom Ghebreyesus announced on Sunday during a visit to Ituri province, the epicentre. “Of course, we’re still working on vaccines and treatments but that doesn’t mean that people cannot recover,” he said, inaugurating a new facility. The Bundibugyo species, last seen in a 2012 outbreak that killed roughly one in four patients, has no approved vaccine or therapy, making the recoveries medically significant. Yet they come against a backdrop of steeply rising case counts: the Africa Centres for Disease Control and Prevention reports 263 confirmed infections and 43 deaths, with more than 1,100 suspected cases under investigation — figures that health officials concede are almost certainly an undercount given limited testing and a volatile security environment.

Viewed from the ground in Ituri and neighbouring North Kivu, the outbreak is unfolding in a region hollowed out by decades of armed conflict and humanitarian crisis. Health workers describe a situation where misinformation flourishes on social media, where families hide the sick, and where aid budgets are being squeezed just as the need escalates. The World Health Organization has expanded testing, and the United States has agreed to support Congo’s use of an experimental antibody treatment in a mid-stage trial, a step Health Minister Roger Kamba called “very promising”. Yet Médecins Sans Frontières warns that the response is dangerously under-resourced, with “grave delays in the arrival of aid and medical personnel”. In Uganda, where nine cases and one death have been confirmed, authorities closed official borders, though the 1,500-kilometre journey between the outbreak zone and the capital Kinshasa has not prevented a suspected case from triggering alarm in Sardinia. African health leaders, writing in the Financial Times, stress that international support is most effective when aligned with continental strategies, not imposed from outside — a clear reference to historical missteps in outbreak response.

The global reverberations were felt acutely over the weekend as countries far from the epidemic curve scrambled to activate protocols. In Brazil, two men — one arriving from Congo, the other from Uganda — were placed in isolation in São Paulo and Rio de Janeiro; both tested positive for other diseases (meningitis and malaria) but remained under observation pending conclusive Ebola tests. In Melbourne, a traveller with compatible symptoms was isolated and later cleared. Italy’s health ministry reported that a Congolese man who flew into Rome from Kinshasa and then travelled to Sardinia was symptomatic and undergoing testing at the Lazzaro Spallanzani institute; officials stressed the risk was “very low” because he had not visited the outbreak zone. Though such scares frequently resolve negatively, they underscore a hard truth: the incubation period of up to 21 days means that any person who has passed through the affected region could carry the virus into an unsuspecting city.

The psychological and political ripple effects are already shaping policy. Canada implemented mandatory three-week quarantine for all travellers who have visited Congo, Uganda or South Sudan in the preceding 21 days, a measure that will remain in force until late August. In Kenya, a high court temporarily halted a US plan to build a quarantine and treatment facility for Americans exposed to the virus, amid domestic opposition and accusations of neo-colonial public health practices. In Sweden, one of only two high-isolation units capable of handling an Ebola patient is currently closed for renovation, a detail that has prompted uncomfortable questions about European preparedness. These developments, taken together, reveal a world that remains fundamentally uneasy about its ability to contain viral threats, even as the immediate risk to countries with robust health systems is judged to be low.

The trajectory of the Bundibugyo outbreak will depend on the speed and coordination of the international response, the willingness of local communities to trust health authorities, and the uncertain biology of a strain that has historically been less lethal than the Zaire species but is now behaving in unpredictable ways. The WHO has confirmed that the outbreak was likely underway well before its detection, and officials fear it could become the largest and most protracted in Congolese history. The recoveries in Bunia are a reminder that Ebola is not always a death sentence, but without a sustained injection of funds, personnel and political attention, the next chapters of this epidemic could be written in cities far from the rainforests of Ituri.